NeoFipronis® (Pronidesivir) is the world’s first officially approved oral antiviral drug specifically developed for the treatment of feline infectious peritonitis (FIP). As a nucleoside analog, its active ingredient is GS-441524, the primary metabolite of Remdesivir, which has been extensively studied and clinically validated for its outstanding anti-coronavirus activity.

NeoFipronis® works by inhibiting the activity of viral RNA-dependent RNA polymerase (RdRp), effectively blocking viral replication and spread. It significantly improves the clinical symptoms and survival rates of cats with FIP. Manufactured with high-purity raw materials and an optimized oral formulation, NeoFipronis® ensures excellent bioavailability and safety, offering real hope of recovery for cats worldwide.

Product Information

• Product Name: NeoFipronis®

• Generic Name: Pronidesivir

• Indication: Treatment of Feline Infectious Peritonitis (FIP)

• Specification: 30 mg/tablet ｜ Oral Tablets ｜ 30 Tablets/Box

Key Features

• Official Approval: Formally approved by the Ministry of Agriculture and Forestry (MAF), with an official drug registration number.

• Global First: The first officially launched oral medication for FIP, offering a safe, non-invasive, and effective treatment option.

• Broad Efficacy: Suitable for wet, dry, neurological, and ocular forms of FIP.

• Easy Administration: No injections required; once-daily oral dosage.

• High Bioavailability: Fast absorption and rapid onset of therapeutic action.

• Excellent Safety Profile: Clinically validated with minimal side effects and good tolerance.

• Globally Trusted: Recommended by veterinarians and trusted by cat owners worldwide.

Dosage & Administration

• Recommended Dosage: Administer 15 mg/kg body weight (equivalent to half a tablet per kg) once daily. For neurological or ocular FIP, consult a veterinarian; dosage may be increased to 30 mg/kg.

• Treatment Duration: Continuous treatment for at least 12 weeks. Severe cases may require up to 16 weeks, with 2 additional weeks of consolidation after symptoms resolve.

• Administration Method: Once daily, preferably on an empty stomach (1 hour before or 2 hours after feeding).

• Precautions:

  
  

• Avoid missed doses.

• Monitor appetite, body temperature, and mental status during treatment.

• Conduct regular blood tests and liver/kidney function checks.

Target Use

For cats diagnosed with Feline Infectious Peritonitis (FIP). Use under the guidance of a licensed veterinarian for optimal safety and effectiveness.